Coverage rates and reasons for pneumococcal vaccination among adults with chronic medical conditions and the elderly in Japan: a web-based, cross-sectional study
Objectives The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is included in the routine immunisation programme for adults aged 65 years and those aged 60–64 years with serious chronic medical conditions (CMCs). To improve the vaccination coverage rates, a catch-up subsidy programme was impl...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/8/e098133.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|